Skip to main content
. Author manuscript; available in PMC: 2014 Jan 1.
Published in final edited form as: Neuroendocrinology. 2012 Aug 28;97(2):160–175. doi: 10.1159/000338669

Fig. 9.

Fig. 9

STX antagonizes the cannabinoid-induced decrease in glutamatergic input onto POMC neurons. A, Spontaneous mEPSCs in a cell perfused with 10 nM STX at baseline and following exposure to 1 μM WIN 55,212-2. B, The cumulative probability plot illustrating the interval between contiguous mEPSCs that substantiates the ability of STX to attenuate the inhibitory effect of WIN 55,212-2 on mEPSC frequency. C, Photomicrographs that illustrate the double-labeling of the cell (1, biocytin-streptavidin-AF488 labeling; 2, α-MSH immunofluorescence visualized by AF546; c, composite overlay).